Abstract
A well-characterized manufacturing process for the large-scale production of recombinant adeno-associated vectors (rAAV) for gene therapy applications is required to meet current and future demands for pre-clinical and clinical studies and potential commercialization. Economic considerations argue in favor of suspension culture-based production. Currently, the only feasible method for large-scale rAAV production utilizes baculovirus expression vectors and insect cells in suspension cultures. To maximize yields and achieve reproducibility between batches, online monitoring of various metabolic and physical parameters is useful for characterizing early stages of baculovirus-infected insect cells. In this study, rAAVs were produced at 40-l scale yielding ~1 × 1015 particles. During the process, dielectric spectroscopy was performed by real time scanning in radio frequencies between 300 kHz and 10 MHz. The corresponding permittivity values were correlated with the rAAV production. Both infected and uninfected reached a maximum value; however, only infected cell cultures permittivity profile reached a second maximum value. This effect was correlated with the optimal harvest time for rAAV production. Analysis of rAAV indicated the harvesting time around 48 h post-infection (hpi), and 72 hpi produced similar quantities of biologically active rAAV. Thus, if operated continuously, the 24-h reduction in the production process of rAAV gives sufficient time for additional 18 runs a year corresponding to an extra production of ~2 × 1016 particles. As part of large-scale optimization studies, this new finding will facilitate the bioprocessing scale-up of rAAV and other bioproducts.
Similar content being viewed by others
References
Acland GM, Aguirre GD, Bennett J, Aleman TS, Cideciyan AV, Bennicelli J, Dejneka NS, Pearce-Kelling SE, Maguire AM, Palczewski K, Hauswirth WW, Jacobson SG (2005) Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol Ther 12:1072–1082
Aitken ML, Moss RB, Waltz DA, Dovey ME, Tonelli MR, McNamara SC, Gibson RL, Ramsey BW, Carter BJ, Reynolds TC (2001) A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Hum Gene Ther 12:1907–1916
Athanasopoulos T, Graham IR, Foster H, Dickson G (2004) Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD). Gene Ther 1S:109–121
Auricchio A, Rolling F (2005) Adeno-associated viral vectors for retinal gene transfer and treatment of retinal diseases. Current Gene Therapy 5:339–348
Bankiewicz KS, Forsayeth J, Eberling JL, Sanchez-Pernaute R, Pivirotto P, Bringas J, Herscovitch P, Carson RE, Eckelman W, Reutter B, Cunningham J (2006) Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC. Mol Ther 14:564–570
Bédard C, Jolicoeur M, Jardin B, Tom R, Perret S, Kamen A (1994) Insect cell density in bioreactor cultures can be estimated from on-line measurements of optical density. Biotechnol Tech 8:605–610
Carter BJ (2005) Adeno-associated virus vectors in clinical trials. Hum Gene Ther 16:541–550
De BP, Heguy A, Hackett NR, Ferris B, Leopold PR, Lee J, Pierre L, Gao G, Wilson JM, Crystal RG (2006) High levels of persistent expression of alpha 1-antitrypsin mediated by the nonhuman primate serotype rh.10 adeno-associated virus despite preexisting immunity to common human adeno-associated viruses. Mol Ther 1:67–76
Emborg ME, Carbon M, Holden JE, During MJ, Ma Y, Tang C, Moirano J, Fitzsimons H, Roitberg BZ, Tuccar E, Roberts A, Kaplitt MG, Eidelberg D (2006) Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism. J Cereb Blood Flow Metab 27:501–509
Flannery JG, Zolotukhin S, Vaquero MI, LaVail MM, Muzyczka N, Hauswirth WW (1997) Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc Natl Acad Sci USA 94:6916–6921
Flotte TR (2005) Recent developments in recombinant AAV-mediated gene therapy for lung diseases. Current Gene Therapy 5:361–366
Fukuchi KI, Tahara K, Kim HD, Maxwell JA, Lewis TL, Accavitti-Loper MA, Kim H, Ponnazhagan S, Lalonde R (2006) Anti-Abeta single chain antibody delivery via adeno-associated virus for treatment of Alzheimer’s disease. Neurobiol Dis 23:502–511
Galarza JM, Latham T, Cupo A (2005) Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge. Viral Immunol 18:365–372
Gentilomi G, Lelli R, D’Angelo M, Langella V, Monaco F, Portanti O, Luciani M, Mirasoli M, Roda A, Zerbini M, Musiani M (2006) Expression of bioactive recombinant bovine interferon-gamma using baculovirus. New Microbiologica 29:19–24
Gregorevic P, Blankinship MJ, Allen JM, Crawford MW, Meuse L, Miller DG, Russell DW, Chamberlain JS (2004) Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 10:828–834
Grieger JC, Samulski RJ (2005) Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications. Adv Biochem Eng Biotechnol 99:119–145
Grimm D, Kern A, Rittner K, Kleinschmidt JA (1998) Novel tools for production and purification of recombinant adeno-associated virus vectors. Hum Gene Ther 9:2745–2760
Halbert CL, Allen JM, Miller AD (2002) Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene. Nat Biotechnol 20:697–701
Handa A, Muramatsu S, Qiu J, Mizukami H, Brown KE (2000) Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors. J Gen Virol 81:2077–2084
Herzog RW (2004) AAV-mediated gene transfer to skeletal muscle. Methods Mol Biol 246:179–194
Kamen AA, Bédard C, Tom R, Perret S, Jardin B (1996) Online monitoring of respiration in recombinant-baculovirus infected and uninfected insect cell bioreactor cultures. Biotechnol Bioeng 50:36–48
Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O’Malley KL, During MJ (1994) Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 8:148–154
Kessler PD, Dubielzig R, Grimm D, Kleinschmidt JA (1996) Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci USA 93:14082–14087
Le Meur G, Stieger K, Smith AJ, Weber M, Deschamps JY, Nivard D, Mendes-Madeira A, Provost N, Pereon Y, Cherel Y, Ali RR, Hamel C, Moullier P, Rolling F (2007) Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium. Gene Ther 4:292–303
Licari P, Bailey JE (1992) Modeling the population dynamics of baculovirus-infected insect cells: optimizing infection strategies for enhanced recombinant protein yields. Biotechnol Bioeng 39:432–441
Limberis MP, Wilson JM (2006) Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered. Proc Natl Acad Sci USA 103:12993–12998
Lucas A, Kremer EJ, Hemmi S, Luis J, Vignon F, Lazennec G (2003) Comparative transductions of breast cancer cells by three DNA viruses. Biochem Biophys Res Commun 4:1011–1016
Manno CS, Arruda VR, Pierce GF, Glader B, Ragni M, Rasko J, Ozelo MC, Hoots K, Blatt P, Konkle B, Dake M, Kaye R, Razavi M, Zajko A, Zehnder J, Nakai H, Chew A, Leonard D, Wright JF, Lessard RR, Sommer JM, Tigges M, Sabatino D, Luk A, Jiang H, Mingozzi F, Couto L, Ertl HC, High KA, Kay MA (2006) Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat Med 12:342–347
Mulvania T, Haynes B, Hedin D (2004) A flow cytometric assay for rapid, accurate determination of baculovirus titers. Bioprocess J 3:47–53
Pethig R, Kell DB (1987) The passive electrical properties of biological systems: their significance in physiology, biophysics and biotechnology. Phys Med Biol 32:933–970
Phi-Wilson J, Harvey J, Goix P, O’Neill R (2001) A technology for rapid acquisition of cell number and viability. American Biotechnology Laboratory, pp 34–36
Plonsky I, Zimmerberg J (1996) The initial fusion pore induced by baculovirus GP64 is large and forms quickly. J Cell Biol 135:1831–1839
Schopf B, Howaldt MW, Bailey JE (1990) DNA distribution and respiratory activity of Spodoptera frugiperda populations infected with wild-type and recombinant Autographa californica nuclear polyhedrosis virus. J Biotechnol 15:169–186
Schwan HP (1957) Electrical properties of tissue and cell suspensions. Adv Biol Med Phys 5:147–209
Shukla AK, Haase W, Reinhart C, Michel H (2006) Functional overexpression and characterization of human bradykinin subtype 2 receptor in insect cells using the baculovirus system. J Cell Biochem 99:868–877
Smith RH, Kotin RM (2001) Adeno-associated viruses. In: Tidona CA, Darai G (eds) The Springer index of viruses. Springer, Berlin, LCC, 1511
Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D, Gown AM, Winther BB, Meuse L, Cohen LK, Thompson AR, Kay MA (1997) Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet 16:270–276
Taticek RA, Shuler ML (1997) Effect of elevated oxygen and glutamine levels on foreign protein production at high cell densities using the insect cell-baculovirus expression system. Biotechnol Bioeng 54:142–152
Urabe M, Ding C, Kotin RM (2002) Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum Gene Ther 13:1935–1943
Xia H, Mao Q, Eliason SL, Harper SQ, Martins IH, Orr HT, Paulson HL, Yang L, Kotin RM, Davidson BL (2004) RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med 10:816–820
Xiao X, Li J, Samulski RJ (1998) Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 72:2224–2232
Xie Q, Hare J, Bu W, Jackson W, Turnigan J, Chapman MS (2004) Large-scale preparation, purification and crystallization of wild-type adeno-associated virus 2. J Virol Methods 122:17–27
Ye L, Lin J, Sun Y, Bennouna S, Lo M, Wu Q, Bu Z, Pulendran B, Compans RW, Yang C (2006) Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies. Virology 351:260–270
Zeiser A, Bedard C, Voyer R, Jardin B, Tom R, Kamen AA (1999) On-line monitoring of the progress of infection in Sf-9 insect cell cultures using relative permittivity measurements. Biotechnol Bioeng 63:122–126
Zeiser A, Elias CB, Voyer R, Jardin B, Kamen AA (2000) On-line monitoring of physiological parameters of insect cell cultures during the growth and infection process. Biotechnol Prog 16:803–808
Acknowledgments
The authors wish to acknowledge the support of J. Shiloach and L. Trinh from NIDDK for facilitating the 40-l bioreactor, L. Yang from NHLBI for providing the baculovirus, and S. Cecchini from NHLBI for the valuable discussions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Negrete, A., Esteban, G. & Kotin, R.M. Process optimization of large-scale production of recombinant adeno-associated vectors using dielectric spectroscopy. Appl Microbiol Biotechnol 76, 761–772 (2007). https://doi.org/10.1007/s00253-007-1030-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-007-1030-9